MedTrace Logo

A Real-world Clinical Study on the Treatment of Menopausal Syndrome With Liuwei Dihuang Pills

NCT06874738 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-03-13

No results posted yet for this study

Summary

To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.

Conditions

  • Menopausal Syndrome

Interventions

DRUG

Liuwei Dihuang pills

Conventional treatment （Hormones, selective 5-hydroxytryptamine reuptake inhibitors, etc.）+ Liu Wei Di Huang Pills

Sponsors & Collaborators

  • Lanxi Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Lianxin Wang · Institute of Basic Research in Clinical Medicine, China Academy of Chinese

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-08
Primary Completion
2026-12-30
Completion
2026-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06874738 on ClinicalTrials.gov